Frontlight ResearchEarly access
CompletedNo phase
An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Key facts
- Who runs it
- Fred Hutchinson Cancer Center
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 1,647 people enrolled
- Started
- 24 Jul 2022
- Ended
- 8 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Experimental Smoking Cessation Program
- Control Smoking Cessation Program
- Record updated
- 22 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Age 18 or older
- Smokes at least one cigarette a day for the past 12 months
- Wants to quit cigarette smoking within the next 30 days (consistent with text messaging intervention trials)
- If concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
- Interested in learning skills to quit smoking
- Willing to be randomly assigned to either intervention
- Resides in United States (US) and will continue to reside in the US for the next 12 months
- Has at least daily access to their own smartphone
- Has text messaging on their smartphone and knows how to download a smartphone application
- Willing and able to read in English, and
- Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)
Who cannot take part
- The reverse of the inclusion criteria
Where in United States
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, United States
About the trial
What the trial wants to find out
This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
The 2 groups in the trial
- Group I (QuitBot Experimental)Treatment being tested
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
Treatment: Experimental Smoking Cessation Program
- Group II (SmokefreeTXT Control)Existing treatment, for comparison
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Treatment: Control Smoking Cessation Program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
- Publications
- Efficacy of a conversational chatbot for cigarette smoking cessation: Protocol of the QuitBot full-scale randomized controlled trial.Contemporary clinical trials, 2024
- Record updated
- 22 May 2026